DOLORES LOPEZ-TERRADA to Early Termination of Clinical Trials
This is a "connection" page, showing publications DOLORES LOPEZ-TERRADA has written about Early Termination of Clinical Trials.
Connection Strength
0.022
-
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol. 2010 Apr 01; 28(10):1772-9.
Score: 0.022
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.